Oncology & Cancer

Immune checkpoint inhibitor therapy tied to cardiac event risk

(HealthDay)—Immune checkpoint inhibitor (ICI) treatment is associated with increased cardiac events among patients with lung cancer and malignant melanoma, according to a study published online Dec. 9 in the European Heart ...

Medical research

Molecules in urine allow doctors to monitor skin cancer

What if you could simply provide a urine sample rather than undergo a painful surgical procedure to find out if your cancer was responding to treatment? It may seem too good to be true, but researchers at Pavol Jozef Šafárik ...

Oncology & Cancer

Scientists identify new target for melanoma immunotherapy

QIMR Berghofer research has found a new reason why some melanoma patients do not respond well to immunotherapy—a discovery that could lead to better-tailored treatments for the potentially deadly cancer.

Oncology & Cancer

Racial differences seen in time to treatment for melanoma

(HealthDay)—Black patients are more likely to experience a longer delay from diagnosis to surgery versus white patients with melanoma, according to a study recently published in the Journal of the American Academy of Dermatology.

Oncology & Cancer

Blocking tumor signals can hinder cancer's spread

For most people who die of cancer, the spread of the initial tumor is to blame. "Metastasis is what kills most cancer patients," says Serge Fuchs, a professor in Penn's School of Veterinary Medicine. "Yet there are not many, ...

Oncology & Cancer

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a review published online ...

Oncology & Cancer

Bereaved individuals may face higher risk of dying from melanoma

Individuals who experience the loss of a partner are less likely to be diagnosed with melanoma but face an increased risk of dying from the disease, according to research published in the British Journal of Dermatology.

page 1 from 6